logo
logo

Sandbrook Capital, Alongside Psp Investments And Imco, Announces Agreement To Acquire Nextwind, A Leading German Renewable Energy Company

Sandbrook Capital, Alongside Psp Investments And Imco, Announces Agreement To Acquire Nextwind, A Leading German Renewable Energy Company

08/09/23, 6:03 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgnewton
Industry
therapeutics
biotechnology
health care
finance
financial services
Sandbrook Capital (“Sandbrook”), a private investment firm dedicated to building businesses crucial to transforming the world’s energy infrastructure, alongside co-investors Public Sector Pension Investment Board (“PSP Investments”) and the Investment Management Corporation of Ontario (“IMCO”), today announce they have signed an agreement to acquire NeXtWind Capital Ltd (“NeXtWind”), a German renewable energy company specializing in acquiring and repowering onshore wind farms, from a syndicate led by Crestline Investors (“Crestline”), an investment management firm head-quartered in Fort Worth, Texas. As part of the transaction, Sandbrook, PSP Investments and IMCO will commit up to US$750 million of equity capital to NeXtWind to acquire its existing portfolio of operating wind assets and to fund future growth.

Company Info

Company
Sandbrook
Location
Newton, Texas, United States
Company info
Abcuro, based in Newton MA, is a clinical stage biotechnology company developing first-in-class immunotherapies for the treatment of autoimmune diseases and cancer through precise modulation of highly cytotoxic T and NK cells. The company is conducting two clinical trials in rare diseases: a Phase 2/3 registrational trial evaluating ABC008 in inclusion body myositis (IBM,) and a Phase 1/2 trial evaluating ABC008 in T cell large granular lymphocytic leukemia. For more information, visit us on LinkedIn and at abcuro.com.